GLP-1s: Shaping Consumer Choices and Retail Futures

GLP-1 medications are emerging as the most powerful force reshaping consumer behavior in generations, and the impacts on retail and consumer brands are measurable and deepening. Changes in appetite, consumption frequency, and product preferences are altering grocery baskets, restaurant spend, alcohol consumption, and demand across key categories, forcing brands to adapt to more selective shoppers who are growing by the millions every year. Caleb Silver, Chief Business Editor of People Inc., takes us inside the Ozembic economy to examine the dynamics of how these blockbuster medications are reshaping the present and future of retail spending.

Speaker Bio

Caleb Silver is an award-winning business journalist and editorial executive with more than three decades of experience covering the most impactful financial stories, trends and developments that have shaped the global economy. He is the Chief Business Editor at People, Inc and has previously worked as the Director of Business News at CNN, the Executive Producer of CNN Money, and a Senior Producer at Bloomberg Television. He is the host of The Investopedia Express podcast, and a frequent contributor to CNBC, MSNBC, NBCNews, ABC Radio, and Yahoo Finance.